Can-Fite BioPharma Ltd. Directors Remuneration Expense
Can-Fite BioPharma Ltd. (CANF) reported Directors Remuneration Expense of $175.00 thousand for the 12-month period ending 2019-12-31, per its 20-F filed 2020-03-27.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:DirectorsRemunerationExpense · last filed 2020-03-27
| Period end | Directors Remuneration Expense 12 month |
|---|---|
| 2019-12-31 | $175.00K 20-F · filed 2020-03-27 |
| 2018-12-31 | $173.00K 20-F · filed 2020-03-27 |
| 2017-12-31 | $198.00K 20-F · filed 2020-03-27 |
| 2016-12-31 | $212.00K 20-F · filed 2019-03-29 |
| 2015-12-31 | $173.00K 6-K · filed 2018-08-08 |